
Please try another search
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor (VEGF) antibody biopolymer that has complete Phase 3 clinical study to treat high prevalence retinal vascular diseases; and in Phase 3 clinical study for the treatment of diabetic retinopathy, wet age-related macular degeneration (AMD), retinal vein occlusion, and diabetic macular edema, as well as in Phase 2/3 clinical study to treat wet AMD. The company’s preclinical stage product candidate includes KSI-501, an anti- interleukin-6 (IL-6) and VEGF-trap bispecific antibody biopolymer conjugate for high prevalence retinal vascular diseases; and KSI-101 (KSI-501P), an unconjugated bispecific protein targeting IL-6 and VEGF developed for patients who have retinal fluid and inflammation. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.
Name | Age | Since | Title |
---|---|---|---|
Charles Wykoff | - | - | Scientific Advisor |
Felix James Baker | 54 | 2015 | Independent Director |
Taiyin Yang | 69 | 2019 | Independent Director |
David Brown | - | - | Scientific Advisor |
Bassil I. Dahiyat | 53 | 2018 | Independent Director |
Robert A. Profusek | 73 | 2018 | Lead Independent Director |
Carl Regillo | - | - | Scientific Advisor |
Michael IP | - | - | Scientific Advisor |
David Boyer | - | - | Scientific Advisor |
Richard S. Levy | 65 | 2018 | Independent Director |
Pravin Dugel | - | - | Scientific Advisor |
Charles A. Bancroft | 63 | 2020 | Independent Director |
Sunil Patel | - | - | Scientific Advisor |
Victor Perlroth | 50 | 2009 | Co-Founder, Chairman, CEO & President |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review